The Claim
Co-supplementation with omega-3 fatty acids and vitamin E for 12 weeks improves gene expression of Lp(a) and Ox-LDL, lipid profiles, and oxidative stress markers in women with polycystic ovary syndrome.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with polycystic ovary syndrome, taking omega-3 fatty acids and vitamin E together for 12 weeks reduces levels of Lp(a) and Ox-LDL gene expression, improves lipid profiles, and lowers oxidative stress markers.
See the scientific wording
Co-supplementation with omega-3 fatty acids and vitamin E for 12 weeks improves multiple biomarkers of cardiovascular risk—including gene expression of Lp(a) and Ox-LDL, lipid profiles, and oxidative stress markers—in women with polycystic ovary syndrome, suggesting a potential multi-targeted therapeutic effect.
Omega-3 fatty acids and vitamin E work together to calm down excessive free radicals and inflammation in the body. This reduces the production of harmful fat particles like Lp(a) and oxidized LDL, while also helping the liver make less bad cholesterol and clear more of it from the blood. The result is a cleaner lipid profile and less damage to blood vessels.
What the research says
1 studyTaking omega-3s and vitamin E together for 12 weeks helped women with PCOS lower harmful fats and stress markers in their blood, which are linked to heart disease. This means the combo may help protect their hearts.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.